Recursion Pharmaceuticals
RXRX
RXRX
126 hedge funds and large institutions have $1.62B invested in Recursion Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 52 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+42
Holders Change %
+50%
% of All Funds
1.95%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
53
Increased
52
Reduced
10
Closed
11
Calls
$2.03M
Puts
$878K
Net Calls
+$1.16M
Net Calls Change
+$101K
Top Buyers
| 1 |
1
BlackRock
New York
|
$116M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$105M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$79.8M |
| 4 |
AI
4
ArchPoint Investors
Coral Gables,
Florida
|
$21.5M |
| 5 |
5
AllianceBernstein
Nashville,
Tennessee
|
$49.3M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CL
126
CRV LLC
Palo Alto,
California
| – | -$16.9M | -733,986 | Closed |
|
127
Alkeon Capital Management
New York
| – | -$12.6M | -548,455 | Closed |
|
|
YRHAM
128
Yong Rong (HK) Asset Management
Sheung Wan,
Hong Kong
| – | -$8.68M | -377,000 | Closed |
|
|
HI
129
HBK Investments
Dallas,
Texas
| – | -$2.3M | -100,000 | Closed |
|
|
RCM
130
Ratan Capital Management
Miami Beach,
Florida
| – | -$807K | -35,069 | Closed |
|
|
SRC
131
Samson Rock Capital
London,
United Kingdom
| – | -$237K | -10,278 | Closed |
|
|
PHK
132
Point72 Hong Kong
Hong Kong
| – | -$69K | -2,987 | Closed |
|
133
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$64 | -2,777 | Closed |
|
|
RE
134
RBC Europe
London,
United Kingdom
| – | -$30.8K | -1,340 | Closed |
|
|
OSAM
135
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$5K | -208 | Closed |
|